A Phase Ib Study Administering Rapamycin (Sirolimus) With Ketoconazole in Patients With Advanced Malignancies.
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2012
At a glance
- Drugs Sirolimus (Primary) ; Ketoconazole
- Indications Cancer
- Focus Adverse reactions
- 12 Feb 2009 Actual patient number (57) reported by ClinicalTrials.gov.
- 12 Feb 2009 Actual completion date (1 Dec 2008) added from ClinicalTrials.gov.
- 12 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.